1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rare Disease Genetic Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Next-Generation Sequencing (NGS)
1.2.3 Array Technology
1.2.4 PCR-based Testing
1.2.5 Fluorescence in Situ Hybridization (FISH)
1.2.6 Sanger Sequencing
1.2.7 Karyotyping
1.2.8 Others
1.3 Market by Application
1.3.1 Global Rare Disease Genetic Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Research Laboratories and CROs
1.3.3 Diagnostic Laboratories
1.3.4 Hospitals and Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Rare Disease Genetic Testing Market Perspective (2017-2028)
2.2 Rare Disease Genetic Testing Growth Trends by Region
2.2.1 Rare Disease Genetic Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Rare Disease Genetic Testing Historic Market Size by Region (2017-2022)
2.2.3 Rare Disease Genetic Testing Forecasted Market Size by Region (2023-2028)
2.3 Rare Disease Genetic Testing Market Dynamics
2.3.1 Rare Disease Genetic Testing Industry Trends
2.3.2 Rare Disease Genetic Testing Market Drivers
2.3.3 Rare Disease Genetic Testing Market Challenges
2.3.4 Rare Disease Genetic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rare Disease Genetic Testing Players by Revenue
3.1.1 Global Top Rare Disease Genetic Testing Players by Revenue (2017-2022)
3.1.2 Global Rare Disease Genetic Testing Revenue Market Share by Players (2017-2022)
3.2 Global Rare Disease Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Rare Disease Genetic Testing Revenue
3.4 Global Rare Disease Genetic Testing Market Concentration Ratio
3.4.1 Global Rare Disease Genetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rare Disease Genetic Testing Revenue in 2021
3.5 Rare Disease Genetic Testing Key Players Head office and Area Served
3.6 Key Players Rare Disease Genetic Testing Product Solution and Service
3.7 Date of Enter into Rare Disease Genetic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rare Disease Genetic Testing Breakdown Data by Type
4.1 Global Rare Disease Genetic Testing Historic Market Size by Type (2017-2022)
4.2 Global Rare Disease Genetic Testing Forecasted Market Size by Type (2023-2028)
5 Rare Disease Genetic Testing Breakdown Data by Application
5.1 Global Rare Disease Genetic Testing Historic Market Size by Application (2017-2022)
5.2 Global Rare Disease Genetic Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Rare Disease Genetic Testing Market Size (2017-2028)
6.2 North America Rare Disease Genetic Testing Market Size by Type
6.2.1 North America Rare Disease Genetic Testing Market Size by Type (2017-2022)
6.2.2 North America Rare Disease Genetic Testing Market Size by Type (2023-2028)
6.2.3 North America Rare Disease Genetic Testing Market Share by Type (2017-2028)
6.3 North America Rare Disease Genetic Testing Market Size by Application
6.3.1 North America Rare Disease Genetic Testing Market Size by Application (2017-2022)
6.3.2 North America Rare Disease Genetic Testing Market Size by Application (2023-2028)
6.3.3 North America Rare Disease Genetic Testing Market Share by Application (2017-2028)
6.4 North America Rare Disease Genetic Testing Market Size by Country
6.4.1 North America Rare Disease Genetic Testing Market Size by Country (2017-2022)
6.4.2 North America Rare Disease Genetic Testing Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Rare Disease Genetic Testing Market Size (2017-2028)
7.2 Europe Rare Disease Genetic Testing Market Size by Type
7.2.1 Europe Rare Disease Genetic Testing Market Size by Type (2017-2022)
7.2.2 Europe Rare Disease Genetic Testing Market Size by Type (2023-2028)
7.2.3 Europe Rare Disease Genetic Testing Market Share by Type (2017-2028)
7.3 Europe Rare Disease Genetic Testing Market Size by Application
7.3.1 Europe Rare Disease Genetic Testing Market Size by Application (2017-2022)
7.3.2 Europe Rare Disease Genetic Testing Market Size by Application (2023-2028)
7.3.3 Europe Rare Disease Genetic Testing Market Share by Application (2017-2028)
7.4 Europe Rare Disease Genetic Testing Market Size by Country
7.4.1 Europe Rare Disease Genetic Testing Market Size by Country (2017-2022)
7.4.2 Europe Rare Disease Genetic Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rare Disease Genetic Testing Market Size (2017-2028)
8.2 Asia-Pacific Rare Disease Genetic Testing Market Size by Type
8.2.1 Asia-Pacific Rare Disease Genetic Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Rare Disease Genetic Testing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Rare Disease Genetic Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific Rare Disease Genetic Testing Market Size by Application
8.3.1 Asia-Pacific Rare Disease Genetic Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Rare Disease Genetic Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Rare Disease Genetic Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific Rare Disease Genetic Testing Market Size by Region
8.4.1 Asia-Pacific Rare Disease Genetic Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Rare Disease Genetic Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Rare Disease Genetic Testing Market Size (2017-2028)
9.2 Latin America Rare Disease Genetic Testing Market Size by Type
9.2.1 Latin America Rare Disease Genetic Testing Market Size by Type (2017-2022)
9.2.2 Latin America Rare Disease Genetic Testing Market Size by Type (2023-2028)
9.2.3 Latin America Rare Disease Genetic Testing Market Share by Type (2017-2028)
9.3 Latin America Rare Disease Genetic Testing Market Size by Application
9.3.1 Latin America Rare Disease Genetic Testing Market Size by Application (2017-2022)
9.3.2 Latin America Rare Disease Genetic Testing Market Size by Application (2023-2028)
9.3.3 Latin America Rare Disease Genetic Testing Market Share by Application (2017-2028)
9.4 Latin America Rare Disease Genetic Testing Market Size by Country
9.4.1 Latin America Rare Disease Genetic Testing Market Size by Country (2017-2022)
9.4.2 Latin America Rare Disease Genetic Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rare Disease Genetic Testing Market Size (2017-2028)
10.2 Middle East & Africa Rare Disease Genetic Testing Market Size by Type
10.2.1 Middle East & Africa Rare Disease Genetic Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Rare Disease Genetic Testing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Rare Disease Genetic Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa Rare Disease Genetic Testing Market Size by Application
10.3.1 Middle East & Africa Rare Disease Genetic Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Rare Disease Genetic Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Rare Disease Genetic Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa Rare Disease Genetic Testing Market Size by Country
10.4.1 Middle East & Africa Rare Disease Genetic Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Rare Disease Genetic Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Quest Diagnostics
11.1.1 Quest Diagnostics Company Details
11.1.2 Quest Diagnostics Business Overview
11.1.3 Quest Diagnostics Rare Disease Genetic Testing Introduction
11.1.4 Quest Diagnostics Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.1.5 Quest Diagnostics Recent Developments
11.2 Centogene
11.2.1 Centogene Company Details
11.2.2 Centogene Business Overview
11.2.3 Centogene Rare Disease Genetic Testing Introduction
11.2.4 Centogene Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.2.5 Centogene Recent Developments
11.3 Invitae Corporation
11.3.1 Invitae Corporation Company Details
11.3.2 Invitae Corporation Business Overview
11.3.3 Invitae Corporation Rare Disease Genetic Testing Introduction
11.3.4 Invitae Corporation Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.3.5 Invitae Corporation Recent Developments
11.4 3billion
11.4.1 3billion Company Details
11.4.2 3billion Business Overview
11.4.3 3billion Rare Disease Genetic Testing Introduction
11.4.4 3billion Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.4.5 3billion Recent Developments
11.5 Arup Laboratories
11.5.1 Arup Laboratories Company Details
11.5.2 Arup Laboratories Business Overview
11.5.3 Arup Laboratories Rare Disease Genetic Testing Introduction
11.5.4 Arup Laboratories Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.5.5 Arup Laboratories Recent Developments
11.6 Eurofins Scientific
11.6.1 Eurofins Scientific Company Details
11.6.2 Eurofins Scientific Business Overview
11.6.3 Eurofins Scientific Rare Disease Genetic Testing Introduction
11.6.4 Eurofins Scientific Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.6.5 Eurofins Scientific Recent Developments
11.7 Strand Life Sciences
11.7.1 Strand Life Sciences Company Details
11.7.2 Strand Life Sciences Business Overview
11.7.3 Strand Life Sciences Rare Disease Genetic Testing Introduction
11.7.4 Strand Life Sciences Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.7.5 Strand Life Sciences Recent Developments
11.8 Ambry Genetics
11.8.1 Ambry Genetics Company Details
11.8.2 Ambry Genetics Business Overview
11.8.3 Ambry Genetics Rare Disease Genetic Testing Introduction
11.8.4 Ambry Genetics Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.8.5 Ambry Genetics Recent Developments
11.9 Perkin Elmer
11.9.1 Perkin Elmer Company Details
11.9.2 Perkin Elmer Business Overview
11.9.3 Perkin Elmer Rare Disease Genetic Testing Introduction
11.9.4 Perkin Elmer Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.9.5 Perkin Elmer Recent Developments
11.10 Macrogen
11.10.1 Macrogen Company Details
11.10.2 Macrogen Business Overview
11.10.3 Macrogen Rare Disease Genetic Testing Introduction
11.10.4 Macrogen Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.10.5 Macrogen Recent Developments
11.11 Baylor Genetics
11.11.1 Baylor Genetics Company Details
11.11.2 Baylor Genetics Business Overview
11.11.3 Baylor Genetics Rare Disease Genetic Testing Introduction
11.11.4 Baylor Genetics Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.11.5 Baylor Genetics Recent Developments
11.12 Color Genomics
11.12.1 Color Genomics Company Details
11.12.2 Color Genomics Business Overview
11.12.3 Color Genomics Rare Disease Genetic Testing Introduction
11.12.4 Color Genomics Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.12.5 Color Genomics Recent Developments
11.13 Preventiongenetics
11.13.1 Preventiongenetics Company Details
11.13.2 Preventiongenetics Business Overview
11.13.3 Preventiongenetics Rare Disease Genetic Testing Introduction
11.13.4 Preventiongenetics Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.13.5 Preventiongenetics Recent Developments
11.14 Progenity
11.14.1 Progenity Company Details
11.14.2 Progenity Business Overview
11.14.3 Progenity Rare Disease Genetic Testing Introduction
11.14.4 Progenity Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.14.5 Progenity Recent Developments
11.15 Coopersurgical
11.15.1 Coopersurgical Company Details
11.15.2 Coopersurgical Business Overview
11.15.3 Coopersurgical Rare Disease Genetic Testing Introduction
11.15.4 Coopersurgical Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.15.5 Coopersurgical Recent Developments
11.16 Fulgent Genetics
11.16.1 Fulgent Genetics Company Details
11.16.2 Fulgent Genetics Business Overview
11.16.3 Fulgent Genetics Rare Disease Genetic Testing Introduction
11.16.4 Fulgent Genetics Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.16.5 Fulgent Genetics Recent Developments
11.17 Myriad Genetics
11.17.1 Myriad Genetics Company Details
11.17.2 Myriad Genetics Business Overview
11.17.3 Myriad Genetics Rare Disease Genetic Testing Introduction
11.17.4 Myriad Genetics Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.17.5 Myriad Genetics Recent Developments
11.18 LabCorp
11.18.1 LabCorp Company Details
11.18.2 LabCorp Business Overview
11.18.3 LabCorp Rare Disease Genetic Testing Introduction
11.18.4 LabCorp Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.18.5 LabCorp Recent Developments
11.19 Opko Health
11.19.1 Opko Health Company Details
11.19.2 Opko Health Business Overview
11.19.3 Opko Health Rare Disease Genetic Testing Introduction
11.19.4 Opko Health Revenue in Rare Disease Genetic Testing Business (2017-2022)
11.19.5 Opko Health Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Rare Disease Genetic Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Next-Generation Sequencing (NGS)
Table 3. Key Players of Array Technology
Table 4. Key Players of PCR-based Testing
Table 5. Key Players of Fluorescence in Situ Hybridization (FISH)
Table 6. Key Players of Sanger Sequencing
Table 7. Key Players of Karyotyping
Table 8. Key Players of Others
Table 9. Global Rare Disease Genetic Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 10. Global Rare Disease Genetic Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Rare Disease Genetic Testing Market Size by Region (2017-2022) & (US$ Million)
Table 12. Global Rare Disease Genetic Testing Market Share by Region (2017-2022)
Table 13. Global Rare Disease Genetic Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 14. Global Rare Disease Genetic Testing Market Share by Region (2023-2028)
Table 15. Rare Disease Genetic Testing Market Trends
Table 16. Rare Disease Genetic Testing Market Drivers
Table 17. Rare Disease Genetic Testing Market Challenges
Table 18. Rare Disease Genetic Testing Market Restraints
Table 19. Global Rare Disease Genetic Testing Revenue by Players (2017-2022) & (US$ Million)
Table 20. Global Rare Disease Genetic Testing Revenue Share by Players (2017-2022)
Table 21. Global Top Rare Disease Genetic Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Disease Genetic Testing as of 2021)
Table 22. Ranking of Global Top Rare Disease Genetic Testing Companies by Revenue (US$ Million) in 2021
Table 23. Global 5 Largest Players Market Share by Rare Disease Genetic Testing Revenue (CR5 and HHI) & (2017-2022)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Rare Disease Genetic Testing Product Solution and Service
Table 26. Date of Enter into Rare Disease Genetic Testing Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Rare Disease Genetic Testing Market Size by Type (2017-2022) & (US$ Million)
Table 29. Global Rare Disease Genetic Testing Revenue Market Share by Type (2017-2022)
Table 30. Global Rare Disease Genetic Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 31. Global Rare Disease Genetic Testing Revenue Market Share by Type (2023-2028)
Table 32. Global Rare Disease Genetic Testing Market Size by Application (2017-2022) & (US$ Million)
Table 33. Global Rare Disease Genetic Testing Revenue Share by Application (2017-2022)
Table 34. Global Rare Disease Genetic Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 35. Global Rare Disease Genetic Testing Revenue Share by Application (2023-2028)
Table 36. North America Rare Disease Genetic Testing Market Size by Type (2017-2022) & (US$ Million)
Table 37. North America Rare Disease Genetic Testing Market Size by Type (2023-2028) & (US$ Million)
Table 38. North America Rare Disease Genetic Testing Market Size by Application (2017-2022) & (US$ Million)
Table 39. North America Rare Disease Genetic Testing Market Size by Application (2023-2028) & (US$ Million)
Table 40. North America Rare Disease Genetic Testing Market Size by Country (2017-2022) & (US$ Million)
Table 41. North America Rare Disease Genetic Testing Market Size by Country (2023-2028) & (US$ Million)
Table 42. Europe Rare Disease Genetic Testing Market Size by Type (2017-2022) & (US$ Million)
Table 43. Europe Rare Disease Genetic Testing Market Size by Type (2023-2028) & (US$ Million)
Table 44. Europe Rare Disease Genetic Testing Market Size by Application (2017-2022) & (US$ Million)
Table 45. Europe Rare Disease Genetic Testing Market Size by Application (2023-2028) & (US$ Million)
Table 46. Europe Rare Disease Genetic Testing Market Size by Country (2017-2022) & (US$ Million)
Table 47. Europe Rare Disease Genetic Testing Market Size by Country (2023-2028) & (US$ Million)
Table 48. Asia Pacific Rare Disease Genetic Testing Market Size by Type (2017-2022) & (US$ Million)
Table 49. Asia Pacific Rare Disease Genetic Testing Market Size by Type (2023-2028) & (US$ Million)
Table 50. Asia Pacific Rare Disease Genetic Testing Market Size by Application (2017-2022) & (US$ Million)
Table 51. Asia Pacific Rare Disease Genetic Testing Market Size by Application (2023-2028) & (US$ Million)
Table 52. Asia Pacific Rare Disease Genetic Testing Market Size by Region (2017-2022) & (US$ Million)
Table 53. Asia Pacific Rare Disease Genetic Testing Market Size by Region (2023-2028) & (US$ Million)
Table 54. Latin America Rare Disease Genetic Testing Market Size by Type (2017-2022) & (US$ Million)
Table 55. Latin America Rare Disease Genetic Testing Market Size by Type (2023-2028) & (US$ Million)
Table 56. Latin America Rare Disease Genetic Testing Market Size by Application (2017-2022) & (US$ Million)
Table 57. Latin America Rare Disease Genetic Testing Market Size by Application (2023-2028) & (US$ Million)
Table 58. Latin America Rare Disease Genetic Testing Market Size by Country (2017-2022) & (US$ Million)
Table 59. Latin America Rare Disease Genetic Testing Market Size by Country (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Rare Disease Genetic Testing Market Size by Type (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Rare Disease Genetic Testing Market Size by Type (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Rare Disease Genetic Testing Market Size by Application (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Rare Disease Genetic Testing Market Size by Application (2023-2028) & (US$ Million)
Table 64. Middle East and Africa Rare Disease Genetic Testing Market Size by Country (2017-2022) & (US$ Million)
Table 65. Middle East and Africa Rare Disease Genetic Testing Market Size by Country (2023-2028) & (US$ Million)
Table 66. Quest Diagnostics Company Details
Table 67. Quest Diagnostics Business Overview
Table 68. Quest Diagnostics Rare Disease Genetic Testing Product
Table 69. Quest Diagnostics Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 70. Quest Diagnostics Recent Developments
Table 71. Centogene Company Details
Table 72. Centogene Business Overview
Table 73. Centogene Rare Disease Genetic Testing Product
Table 74. Centogene Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 75. Centogene Recent Developments
Table 76. Invitae Corporation Company Details
Table 77. Invitae Corporation Business Overview
Table 78. Invitae Corporation Rare Disease Genetic Testing Product
Table 79. Invitae Corporation Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 80. Invitae Corporation Recent Developments
Table 81. 3billion Company Details
Table 82. 3billion Business Overview
Table 83. 3billion Rare Disease Genetic Testing Product
Table 84. 3billion Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 85. 3billion Recent Developments
Table 86. Arup Laboratories Company Details
Table 87. Arup Laboratories Business Overview
Table 88. Arup Laboratories Rare Disease Genetic Testing Product
Table 89. Arup Laboratories Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 90. Arup Laboratories Recent Developments
Table 91. Eurofins Scientific Company Details
Table 92. Eurofins Scientific Business Overview
Table 93. Eurofins Scientific Rare Disease Genetic Testing Product
Table 94. Eurofins Scientific Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 95. Eurofins Scientific Recent Developments
Table 96. Strand Life Sciences Company Details
Table 97. Strand Life Sciences Business Overview
Table 98. Strand Life Sciences Rare Disease Genetic Testing Product
Table 99. Strand Life Sciences Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 100. Strand Life Sciences Recent Developments
Table 101. Ambry Genetics Company Details
Table 102. Ambry Genetics Business Overview
Table 103. Ambry Genetics Rare Disease Genetic Testing Product
Table 104. Ambry Genetics Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 105. Ambry Genetics Recent Developments
Table 106. Perkin Elmer Company Details
Table 107. Perkin Elmer Business Overview
Table 108. Perkin Elmer Rare Disease Genetic Testing Product
Table 109. Perkin Elmer Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 110. Perkin Elmer Recent Developments
Table 111. Macrogen Company Details
Table 112. Macrogen Business Overview
Table 113. Macrogen Rare Disease Genetic Testing Product
Table 114. Macrogen Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 115. Macrogen Recent Developments
Table 116. Baylor Genetics Company Details
Table 117. Baylor Genetics Business Overview
Table 118. Baylor Genetics Rare Disease Genetic Testing Product
Table 119. Baylor Genetics Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 120. Baylor Genetics Recent Developments
Table 121. Color Genomics Company Details
Table 122. Color Genomics Business Overview
Table 123. Color Genomics Rare Disease Genetic Testing Product
Table 124. Color Genomics Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 125. Color Genomics Recent Developments
Table 126. Preventiongenetics Company Details
Table 127. Preventiongenetics Business Overview
Table 128. Preventiongenetics Rare Disease Genetic Testing Product
Table 129. Preventiongenetics Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 130. Preventiongenetics Recent Developments
Table 131. Progenity Company Details
Table 132. Progenity Business Overview
Table 133. Progenity Rare Disease Genetic Testing Product
Table 134. Progenity Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 135. Progenity Recent Developments
Table 136. Coopersurgical Company Details
Table 137. Coopersurgical Business Overview
Table 138. Coopersurgical Rare Disease Genetic Testing Product
Table 139. Coopersurgical Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 140. Coopersurgical Recent Developments
Table 141. Fulgent Genetics Company Details
Table 142. Fulgent Genetics Business Overview
Table 143. Fulgent Genetics Rare Disease Genetic Testing Product
Table 144. Fulgent Genetics Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 145. Fulgent Genetics Recent Developments
Table 146. Myriad Genetics Company Details
Table 147. Myriad Genetics Business Overview
Table 148. Myriad Genetics Rare Disease Genetic Testing Product
Table 149. Myriad Genetics Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 150. Myriad Genetics Recent Developments
Table 151. LabCorp Company Details
Table 152. LabCorp Business Overview
Table 153. LabCorp Rare Disease Genetic Testing Product
Table 154. LabCorp Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 155. LabCorp Recent Developments
Table 156. Opko Health Company Details
Table 157. Opko Health Business Overview
Table 158. Opko Health Rare Disease Genetic Testing Product
Table 159. Opko Health Revenue in Rare Disease Genetic Testing Business (2017-2022) & (US$ Million)
Table 160. Opko Health Recent Developments
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rare Disease Genetic Testing Market Share by Type: 2021 VS 2028
Figure 2. Next-Generation Sequencing (NGS) Features
Figure 3. Array Technology Features
Figure 4. PCR-based Testing Features
Figure 5. Fluorescence in Situ Hybridization (FISH) Features
Figure 6. Sanger Sequencing Features
Figure 7. Karyotyping Features
Figure 8. Others Features
Figure 9. Global Rare Disease Genetic Testing Market Share by Application: 2021 VS 2028
Figure 10. Research Laboratories and CROs Case Studies
Figure 11. Diagnostic Laboratories Case Studies
Figure 12. Hospitals and Clinics Case Studies
Figure 13. Others Case Studies
Figure 14. Rare Disease Genetic Testing Report Years Considered
Figure 15. Global Rare Disease Genetic Testing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 16. Global Rare Disease Genetic Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Rare Disease Genetic Testing Market Share by Region: 2021 VS 2028
Figure 18. Global Rare Disease Genetic Testing Market Share by Players in 2021
Figure 19. Global Top Rare Disease Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Disease Genetic Testing as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by Rare Disease Genetic Testing Revenue in 2021
Figure 21. North America Rare Disease Genetic Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 22. North America Rare Disease Genetic Testing Market Size Market Share by Type (2017-2028)
Figure 23. North America Rare Disease Genetic Testing Market Size Market Share by Application (2017-2028)
Figure 24. North America Rare Disease Genetic Testing Market Size Share by Country (2017-2028)
Figure 25. United States Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Canada Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Europe Rare Disease Genetic Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 28. Europe Rare Disease Genetic Testing Market Size Market Share by Type (2017-2028)
Figure 29. Europe Rare Disease Genetic Testing Market Size Market Share by Application (2017-2028)
Figure 30. Europe Rare Disease Genetic Testing Market Size Share by Country (2017-2028)
Figure 31. Germany Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. France Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. U.K. Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Italy Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Russia Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Nordic Countries Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Asia-Pacific Rare Disease Genetic Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 38. Asia Pacific Rare Disease Genetic Testing Market Size Market Share by Type (2017-2028)
Figure 39. Asia Pacific Rare Disease Genetic Testing Market Size Market Share by Application (2017-2028)
Figure 40. Asia Pacific Rare Disease Genetic Testing Market Size Share by Region (2017-2028)
Figure 41. China Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Japan Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. South Korea Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Southeast Asia Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. India Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Australia Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 47. Latin America Rare Disease Genetic Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Latin America Rare Disease Genetic Testing Market Size Market Share by Type (2017-2028)
Figure 49. Latin America Rare Disease Genetic Testing Market Size Market Share by Application (2017-2028)
Figure 50. Latin America Rare Disease Genetic Testing Market Size Share by Country (2017-2028)
Figure 51. Mexico Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Brazil Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Middle East & Africa Rare Disease Genetic Testing Market Size YoY (2017-2028) & (US$ Million)
Figure 54. Middle East and Africa Rare Disease Genetic Testing Market Size Market Share by Type (2017-2028)
Figure 55. Middle East and Africa Rare Disease Genetic Testing Market Size Market Share by Application (2017-2028)
Figure 56. Middle East and Africa Rare Disease Genetic Testing Market Size Share by Country (2017-2028)
Figure 57. Turkey Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. Saudi Arabia Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. UAE Rare Disease Genetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 60. Quest Diagnostics Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 61. Centogene Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 62. Invitae Corporation Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 63. 3billion Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 64. Arup Laboratories Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 65. Eurofins Scientific Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 66. Strand Life Sciences Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 67. Ambry Genetics Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 68. Perkin Elmer Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 69. Macrogen Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 70. Baylor Genetics Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 71. Color Genomics Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 72. Preventiongenetics Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 73. Progenity Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 74. Coopersurgical Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 75. Fulgent Genetics Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 76. Myriad Genetics Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 77. LabCorp Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 78. Opko Health Revenue Growth Rate in Rare Disease Genetic Testing Business (2017-2022)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
